Beneficial role of adipose-derived mesenchymal stem cells from microfragmented fat in a murine model of duchenne muscular dystrophy

Muscle Nerve. 2019 Sep;60(3):328-335. doi: 10.1002/mus.26614. Epub 2019 Jul 16.

Abstract

Introduction: No etiologic therapy is available for Duchenne muscular dystrophy (DMD), but mesenchymal stem cells were shown to be effective in preclinical models of DMD. The objective of this study is to investigate the effect of microfragmented fat extracted on a murine model of DMD.

Methods: Fat tissue was extracted from healthy human participants and injected IM into DMD mice. Histological analysis, cytokines, and force measurement were performed up to 4 weeks after injection.

Results: Duchenne muscular dystrophy mice injected with microfragmented fat exhibited an improved muscle phenotype (decreased necrosis and fibrosis), a decrease of inflammatory cytokines, and increased strength.

Discussion: Administration of microfragmented fat in key muscles may improve muscular phenotype in patients with DMD. Muscle Nerve, 2019.

Keywords: Duchenne muscular dystrophy; adipose-derived mesenchymal stem cells; mesenchymal stem cells; microfragmented fat; stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / pathology
  • Animals
  • Disease Models, Animal
  • Dystrophin / genetics*
  • Mesenchymal Stem Cells / cytology*
  • Mice, Inbred C57BL
  • Muscle Strength / physiology
  • Muscle, Skeletal / pathology*
  • Muscular Dystrophy, Duchenne / genetics*

Substances

  • Dystrophin